<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of clonal diseases of pluripotent hematopoietic stem or progenitor cells </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> are characterized by ineffective hematopoiesis, <z:mp ids='MP_0006042'>increased apoptosis</z:mp>, peripheral blood cytopenias, and propensity to evolve into <z:hpo ids='HP_0004808'>acute myelogenous leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>OBJECTIVES: The aim of our investigation was to compare the usefulness of classic cytogenetics and fluorescence in situ hybridization (FISH) to detect chromosome aberrations in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS AND METHODS: The study was carried out in a group of 58 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>G-banding using trypsin and Giemsa (GTG banding) and FISH with a panel of five molecular probes for aberrations with prognostic significance in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (cen7/8, 5q31, 7q22/q35, 17p13, 20q13.3) were performed on bone marrow cells </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The use of GTG technique allowed to detect chromosome aberrations in 25 (43.1%) subjects </plain></SENT>
<SENT sid="6" pm="."><plain>However, the additional use of FISH showed the presence of aberrations also in additional 10 (17.2%) patients, which shifted 11 patients from one cytogenetic category to another </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The use of FISH with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> probe panel beside classic cytogenetics improves detection of chromosome aberrations, and also stratification of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients to prognostic groups </plain></SENT>
<SENT sid="8" pm="."><plain>Both methods should be used simultaneously in every genetically diagnosed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patient </plain></SENT>
</text></document>